학술논문

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Document Type
Article
Source
In Annals of Oncology May 2021 32(5):620-630
Subject
Thoracic tumors
Language
ISSN
0923-7534